Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma

BACKGROUND: The cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) is widely considered as a pivotal immune checkpoint molecule to suppress antitumor immunity. However, the significance of soluble CTLA-4 (sCTLA-4) remains unclear in the patients with brain glioma. Here we aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiajia, Tian, Xiaoyi, Wang, Yan, Kang, Xixiong, Song, Wenqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132428/
https://www.ncbi.nlm.nih.gov/pubmed/34006227
http://dx.doi.org/10.1186/s12865-021-00422-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132428/
https://www.ncbi.nlm.nih.gov/pubmed/34006227
http://dx.doi.org/10.1186/s12865-021-00422-y

Ejemplares similares